![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The high proportion of false negative results in cervical cancer screening and the lack of an inexpensive and rapid method for rescreening cervical smears led us to search for a way to maximize the detection of false negative cases. We describe a simple, rapid, and inexpensive procedure, the cervical acid phosphatase-Papanicolaou test (CAP-PAP test), that can alleviate the problem of false negatives. For research purposes, CAP-PAP test is immediately applicable in all laboratories currently doing the standard PAP test. It does not require special training for screeners or purchasing of additional expensive instruments. Additional cost per test is less than $1.00. The CAP-PAP test is compatible with automation. (The J Histotechnol 22:43, 1999)
Keywords: